Back to Back Issues Page
Would You Take Something the Manufacturer Admits Can Give You Heart Attacks?
May 17, 2018

How Not to Be A Victim of Drug Companies


If you like this newsletter, please do a friend and me a big favor and "pay it forward" Forward it to a friend

If a friend did forward this to you and if you like what you read, please subscribe by visiting... Newsletter Page

FDA on safety grounds rejected Lipocine's testosterone drug, Tlando

This Low T drug has so many dangerous side effects, the FDA decided to ere on the side of caution

Read about why FDA refused to approve Tlando on this blog

You would remember that the FDA approved Addyi aka Flibanserin aka Female Viagra in 2015
This approval drew many criticisms.


Well, the approval came because of the pressure put on the FDA by a women advocacy group, Even The Score
This group accused the FDA of gender bias

Certainly, IF the FDA could approve a male Viagra, why not a female Viagra?
This group was actually a front group set up by Sprout Pharmaceutical, the manufacturer of Addyi


Here is what concerns people even more..

..the serious side effects Addyi

Besides, it barely beat a placebo in tests

Sex is a biological necessity

The anxiety men and women feel if they do not feel the natural urge to do it is what drug companies are scrambling to monetize

One of the methods for exploiting this fear is Pfizer targeting its Viagra ads to women!

Never mind that Viagra is a male drug

But there is a method to that madness when you think about it!

Please share this!


Take care of your health-it's your most precious asset!

Till next time, I hope you'll always make non-toxic choices

Thank YOU

Comments? Ideas? Feedback? I'd love to hear from you. Just reply to this newsletter and tell me what you think! I promise I will personally reply to every email


Share this newsletter with your circles, friends etc

If this email was forwarded to you by a friend, here is where you can subscribe to Natural Health News so you too can start enjoying contents like this one

Thank you.

Back to Back Issues Page